Del Carmen Jeffrey's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Jun 11, 2024
- Accession no.
- 0001161697-24-000262
- Filed
- Jun 11, 2024
- Trade date
- Jun 7, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $121.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Del Carmen JeffreyCIK 0001816477 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −7,541 | $16.07 | −$121,183.87 | 18,427 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.